A drug has high potency but limited clinical usefulness. Which explanation best fits this scenario?

• A. It has high potency but low efficacy or adverse effects limit dosing.
• B. It has high potency and high efficacy, leading to strong clinical usefulness.
• C. Potency directly determines the therapeutic index.
• D. Rapid metabolism accounts for limited exposure.

Answer: (A)

Potency is about how much drug you need to get a given effect, while efficacy is about the maximum effect the drug can produce. If a drug is highly potent, it means you can achieve a response with a very small dose, but that doesn’t guarantee good clinical usefulness. If its maximal effect is limited (low efficacy) or if dosing is constrained by adverse effects at the doses needed to reach a therapeutic level, the overall usefulness drops. In other words, you can achieve some effect with little drug, but you can’t reach a strong enough therapeutic benefit without hitting harmful side effects, so its clinical value is limited.

If a drug had both high potency and high efficacy, it would typically be very useful clinically. The idea that potency directly determines the therapeutic index isn’t correct—the therapeutic index depends on safety margins between effective and toxic doses, not potency alone. And while rapid metabolism can reduce exposure, that explains duration rather than why a highly potent drug would be of limited usefulness on its own; it doesn’t address the necessary efficacy or safety constraints that cap clinical value.